LOG IN
SIGN UP
MARKET
BSX
BSX
Boston Scien Cp
NYSE
Real-time Quotes | Nasdaq Last Sale
37.80
+0.30
+0.80%
After Hours: 37.80 0 0.00% 18:48 06/29 EDT
OPEN
37.57
PREV CLOSE
37.50
HIGH
37.90
LOW
37.28
VOLUME
5.75M
TURNOVER
0
52 WEEK HIGH
47.50
52 WEEK LOW
34.98
MARKET CAP
54.04B
P/E (TTM)
71.96
1D
5D
1M
3M
1Y
5Y
Boston Scientific Announces Conference Call Discussing Second Quarter 2022 Results
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ending June 30, 2022 on Wednesday, July 27, 2022 at 8:00 a.m. EDT. The call will be hosted by Mike Mahone...
PR Newswire · 13h ago
Boston Scientific to open Atlanta plant, latest life sciences win
A massive medical device manufacturer plans to open a plant in the Atlanta suburbs as the life sciences industry grows. Boston Scientific Corp. (NYSE: BSX) will invest $62.5 million into the Johns Creek manufacturing and supply chain facility, according t...
American City Business Journals · 15h ago
Insider Sell: Boston Scientific
MT Newswires · 2d ago
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.66% on an annualized basis producing an average annual return of 20.68%. Currently, Boston Scientific has a market capitalization of $54.31 billion.
Benzinga · 2d ago
5 Analysts Have This to Say About Boston Scientific
Over the past 3 months, 5 analysts have published their opinion on Boston Scientific (NYSE:BSX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade ove...
Benzinga · 5d ago
Boston Scientific Reaffirms Its Commitment to Employee Mental Health and Well-Being
By Wendy Carruthers, Senior Vice President HR at Boston Scientific
News Direct · 5d ago
Top Research Reports for Adobe, Southern Company & Northrop Grumman
Today's Research Daily features new research reports on 16 major stocks, including Adobe Inc. (ADBE), The Southern Company (SO), and Northrop Grumman Corporation (NOC).
Zacks · 06/22 16:14
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Benzinga · 06/17 17:36
No Data
Learn about the latest financial forecast of BSX. Analyze the recent business situations of Boston Scien Cp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating
Based on 27 analysts
Buy
Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.
37.04%Strong Buy
51.85%Buy
11.11%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average BSX stock price target is 49.82 with a high estimate of 55.50 and a low estimate of 44.00.
Current 37.80
EPS
Actual
Estimate
0.110.230.340.45
Institutional Holdings
Institutions: 1.21K
Institutional Holdings: 1.47B
% Owned: 102.56%
Shares Outstanding: 1.43B
TypeInstitutionsShares
Increased
336
65.27M
New
102
9.06M
Decreased
279
71.29M
Sold Out
80
4.28M
- Performance
- Asset Allocation
- Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.32%
Healthcare Equipment & Supplies
+0.76%
Key Executives
Chairman/President/Chief Executive Officer/Director
Michael Mahoney
Chief Financial Officer/Executive Vice President
Daniel Brennan
Executive Vice President/Director of Human Resources
Wendy Carruthers
Executive Vice President
Arthur Butcher
Executive Vice President
Joseph Fitzgerald
Executive Vice President
Edward Mackey
Executive Vice President
Ian Meredith
Executive Vice President
Jeffrey Mirviss
Executive Vice President
David Pierce
Executive Vice President
Eric Thepaut
Senior Vice President/Chief Information Officer
Jodi Eddy
Senior Vice President/General Counsel/Secretary
Vance Brown
Senior Vice President
Michael Jones
Senior Vice President
Maulik Nanavaty
Senior Vice President
Scott Olson
Senior Vice President
Meghan Scanlon
Senior Vice President
John Sorenson
Lead Director/Independent Director
Edward Ludwig
Independent Director
Nelda Connors
Independent Director
Charles Dockendorff
Independent Director
Yoshiaki Fujimori
Independent Director
Donna James
Independent Director
David Roux
Independent Director
John Sununu
Independent Director
David Wichmann
Independent Director
Ellen Zane
No Data
No Data
About BSX
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.
Webull offers kinds of Boston Scientific Corporation stock information, including NYSE:BSX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BSX stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading BSX stock methods without spending real money on the virtual paper trading platform.